drugset / Trial / NCT04405804
Early Administration of Ivabradine in Children With Heart Failure
Phase 2
Unknown
9 enrolled
Bambino Gesù Hospital and Research Institute
Ministero della Salute, Italy · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a monocentric, prospective, single arm, not for profit study. It is designed to study the early use of ivabradine in patients with dilated cardiomyopathy and Ejection Fraction (EF) \< 45%.
Timeline
- Start
- 2020-06-20
- Primary completion
- 2021-01
- Completion
- 2021-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivabradine | Small molecule | 0.2 mg/kg | — |
| Subject | Ivabradine | Small molecule | 0.3 mg/kg | — |
| Subject | Ivabradine | Small molecule | 15 mg | — |